On January 1, 2020 (the first day of its fiscal year) Wildhorse Ltd. acquired a patent which gave the company the right to use a production process. The process met the six criteria for capitalization as an intangible asset. Below is a listing of the events relating to the patent over the five fiscal years from 2020 through 2024:

2020:
		on January 1, acquired the patent for the production process from its inventory for a cash payment of $17,400,000, and determined that the process had an indefinite useful life.
		on December 31, tested the patent for impairment and determined that its fair value was $18,400,000.
2021:
		on December 31, tested the patent for impairment and determined that its fair value was $15,400,000.
2022:
		on December 31, tested the patent for impairment and determined that its fair value was $16,300,000.
2023:
		on January 1, determined that the useful life of the patent was no longer indefinite, its carrying amount was recoverable, its estimated remaining useful life was 7 years, its estimated residual value was $0 and the pattern of economic benefits to be obtained from the patent during those 7 years was evenly spread over those 7 years.
		on December 31, tested the process for impairment and recoverability and determined that its fair value was $1,000,000 and its carrying amount was recoverable.
2024:
		on December 31, tested the patent for impairment and recoverability and determined that its fair value was $0 and its carrying amount was not recoverable.

record entry for

Jan 1, 2020

Dec 31,2020

Dece 31,2021

Dec 31, 2022

Dec 31, 2023

Dec 31, 2024 (to record amortization expense)

Dec 31, 2024 (to record loss on impairment)